Skip to main content

Richard E. Pratley, MD

Richard E. Pratley, MD

Medical Director at the AdventHealth Diabetes Institute, Senior Investigator, Diabetes Program Lead at the Translational Research Institute

Translational Research, Infectious Disease

Pratley

Overview

Richard Pratley, MD, is a board-certified internal medicine physician and nationally recognized diabetes expert with advanced training in gerontology, geriatrics and clinical physiology and metabolism. He sees patients at AdventHealth Medical Group’s diabetes and endocrine specialty practice in Orlando and The Villages while also serving as the Medical Director of the AdventHealth Diabetes Institute and as a senior scientist in diabetes research for AdventHealth. He is a leading authority on new and emerging treatments for diabetes and its comorbidities, which is why many area physicians refer their patients to him for advanced diabetes care. Dr. Pratley earned his medical degree at Wayne State University in Detroit and undertook his residency at the University of Michigan. He next completed three consecutive fellowships in clinical physiology and metabolism, gerontology and geriatrics, and geriatrics at the National Institute on Aging in Baltimore, Johns Hopkins University and the University of Michigan, respectively.

Articles

Let's Be More Sensitive-How SGLT-2 Inhibitors and GLP-1 Receptor Agonists Affect beta-Cell Function in Type 2 Diabetes Comment on "Improved Beta Cell Glucose Sensitivity Plays Predominant Role in the Decrease in HbA1c with Cana and Lira in T2DM" by Ali et

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

2020

Genetic Discrimination Between LADA and Childhood-Onset Type 1 Diabetes Within the MHC

DIABETES CARE

2020

Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses

BMJ OPEN

2020

Pharmacological therapies to address obesity in type 1 diabetes

CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY

2020

Characteristics of adult- compared to childhood-onset type 1 diabetes

DIABETIC MEDICINE

2020

Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes A Randomized Clinical Trial

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

2020

An improvement in skeletal muscle mitochondrial capacity with short-term aerobic training is associated with changes in Tribbles 1 expression

PHYSIOLOGICAL REPORTS

2020

Machine Learning to Identify Predictors of Glycemic Control in Type 2 Diabetes: An Analysis of Target HbA1c Reduction Using Empagliflozin/Linagliptin Data

PHARMACEUTICAL MEDICINE

2019

Predicting and understanding the response to short-term intensive insulin therapy in people with early type 2 diabetes

MOLECULAR METABOLISM

2019

Pioglitazone Therapy in Patients With Stroke and Prediabetes A Post Hoc Analysis of the IRIS Randomized Clinical Trial

JAMA NEUROLOGY

2019

Education & Training

Education

Wayne State University School of Medicine; University of Michigan- Ann Arbor; John Hopkins School of Medicine; University of Michigan - Dearborn

Residency

University of Michigan, Ann Arbor, MI

Fellowship

University of Michigan, Ann Arbor, MI; Johns Hopkins University, Baltimore, MD

Board Certifications

American Board of Internal Medicine

Associated Clinical Trials

NCT03763877

A randomized, double-blind, placebo-controlled, parallel group trial to assess the efficacy and safety of PXL770 versus placebo after 12 weeks of treatment in patients with Nonalcoholic Fatty Liver Disease (NAFLD) with or without type 2 diabetes mellitus

Icon for trial | A randomized, double-blind, placebo-controlled, parallel group trial to assess the efficacy and safety of PXL770 versus placebo after 12 weeks of treatment in patients with Nonalcoholic Fatty Liver Disease (NAFLD) with or without type 2 diabetes mellitus

You are being asked to participate in this research study because you have Non-alcoholic Fatty Liver Disease (NAFLD), a condition associated with fat buildup in the liver, with or without type 2 diabetes mellitus (T2DM). ...

NCT01942694

Vitamin D and Type 2 Diabetes

Icon for trial | Vitamin D and Type 2 Diabetes

Diabetes is a serious condition affecting about 1 in 10 people in the United States. Lifestyle changes, such as healthy eating, exercise and weight loss, can decrease the chances of developing diabetes. However, many peo ...

Automated Insulin Delivery in Elderly with Type 1 Diabetes

Icon for trial | Automated Insulin Delivery in Elderly with Type 1 Diabetes

This study is currently enrolling.

The purpose of this study is to see if features of an automated insulin delivery system (study system) can reduce low blood sugar (hypoglycemia) in older adults with type 1 diabetes. We expect up to 150 people will take ...